3rd Party Medical Device Industry News

AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System | Reports Boston Scientific as First-Line Treatment for Persistent Atrial Fibrillation

The AVANT GUARD clinical trial will evaluate the safety and [...]

By |2023-12-29T16:22:20+00:00December 29, 2023|3rd Party Medical Device Industry News|Comments Off on AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System | Reports Boston Scientific as First-Line Treatment for Persistent Atrial Fibrillation
Go to Top